NASDAQ:TXMD TherapeuticsMD (TXMD) Stock Price, News & Analysis $1.83 +0.04 (+2.23%) (As of 07/26/2024 ET) Add Compare Share Share Today's Range$1.72▼$1.8450-Day Range$1.51▼$2.2252-Week Range$1.43▼$4.35Volume7,264 shsAverage Volume18,025 shsMarket Capitalization$21.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Get TherapeuticsMD alerts: Email Address Ad DTIHow to build the ultimate dividend portfolioThere’s a free dividend workshop that shows how anyone can build the ultimate dividend workshop in 3 basic steps? PLUS: You’ll get the names and tickers of the Best Dividend Stocks for FREE… This way, by the time you finish the workshop you’ll be fully equipped with the knowledge to start unlocking dividend checks for yourself… Over and over again.Click here and I’ll show you how to build the ultimate dividend portfolio. About TherapeuticsMD Stock (NASDAQ:TXMD)TherapeuticsMD, Inc. operates as a pharmaceutical royalty company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY, BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brand names. The company sells its prescription pharmaceutical products and prenatal vitamin products through wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.Read More TXMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart TXMD Stock News HeadlinesJuly 24 at 4:15 AM | americanbankingnews.comTherapeuticsMD (NASDAQ:TXMD) Earns Hold Rating from Analysts at StockNews.comJuly 19, 2024 | americanbankingnews.comTherapeuticsMD (NASDAQ:TXMD) Now Covered by Analysts at StockNews.comJuly 27, 2024 | Darwin (Ad)Top Stock Unveiled!Ready to discover the standout stock of 2024? We’ve identified a single buy & hold gem that’s poised to redefine your portfolio. Download our exclusive report now and dive into the Insights. Click below to opt-in and receive up to two additional free bonus subscriptions. Unsubscribe at any time.June 28, 2024 | investorplace.comTXMD Stock Earnings: TherapeuticsMD Reported Results for Q4 2023May 15, 2024 | finance.yahoo.comTherapeuticsMD, Inc. (TXMD) Stock Price, News, Quote & History - Yahoo FinanceMay 10, 2024 | investorplace.comTXMD Stock Earnings: TherapeuticsMD Reported Results for Q1 2024May 10, 2024 | businesswire.comTherapeuticsMD Announces First Quarter 2024 Financial ResultsMarch 29, 2024 | businesswire.comTherapeuticsMD Announces Full Year 2023 Financial ResultsJuly 27, 2024 | Crypto Swap Profits (Ad)625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.March 12, 2024 | msn.com25 Countries With Highest Abortion RatesMarch 10, 2024 | sg.finance.yahoo.comTherapeuticsMD, Inc. (TXMD) stock historical prices & data – Yahoo FinanceDecember 29, 2023 | morningstar.comTherapeuticsMD Inc TXMDNovember 15, 2023 | nasdaq.comDaily Markets: Today Brings Producer Prices, Retail Sales DataNovember 14, 2023 | marketwatch.comTherapeuticsMD to Consider Strategic AlternativesNovember 14, 2023 | msn.comTherapeuticsMD exploring strategic alternatives for companyNovember 14, 2023 | finance.yahoo.comTherapeuticsMD Announces Third Quarter 2023 Financial ResultsOctober 4, 2023 | bizjournals.comBoca Raton-based prescription service announces layoffs, says a third of workforce could be cutSeptember 20, 2023 | marketwatch.comTherapeuticsMD Inc. stock falls Wednesday, underperforms marketSee More Headlines Receive TXMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings5/10/2024Today7/26/2024Next Earnings (Estimated)8/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Pharmaceutical preparations Sub-IndustryPharmaceutical Products Current SymbolNASDAQ:TXMD Previous SymbolNYSEMKT:TXMD CUSIPN/A CIK25743 Webwww.therapeuticsmd.com Phone(561) 961-1900Fax561-431-3389Employees420Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,280,000.00 Net MarginsN/A Pretax Margin-520.52% Return on Equity-21.15% Return on Assets-13.08% Debt Debt-to-Equity RatioN/A Current Ratio1.78 Quick Ratio1.78 Sales & Book Value Annual Sales$1.30 million Price / Sales16.23 Cash FlowN/A Price / Cash FlowN/A Book Value$2.77 per share Price / Book0.66Miscellaneous Outstanding Shares11,530,000Free Float11,394,000Market Cap$21.10 million OptionableOptionable Beta1.06 13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.Get This Free Report Key ExecutivesGovernor Thomas G. Thompson (Age 82)Executive Chairman Comp: $160kMr. Marlan D. Walker J.D. (Age 49)Chief Executive Officer Comp: $661.42kMr. Joseph A. Ziegler (Age 50)Principal Financial & Accounting Officer Comp: $84.64kMr. Robert G. Finizio (Age 53)Co-Founder Comp: $7.51kMr. Douglas SteelmanVice President of Market AccessKey CompetitorsOsmotica PharmaceuticalsNASDAQ:OSMTBeyondSpringNASDAQ:BYSIKronos BioNASDAQ:KRONInstil BioNASDAQ:TILMarinus PharmaceuticalsNASDAQ:MRNSView All CompetitorsInsiders & InstitutionsGabelli Funds LLCSold 17,000 shares on 5/15/2024Ownership: 0.104%Prosperity Consulting Group LLCBought 24,500 shares on 5/1/2024Ownership: 0.212%Marlan D WalkerSold 14,500 sharesTotal: $33,495.00 ($2.31/share)View All Insider TransactionsView All Institutional Transactions TXMD Stock Analysis - Frequently Asked Questions How have TXMD shares performed this year? TherapeuticsMD's stock was trading at $2.25 at the beginning of the year. Since then, TXMD shares have decreased by 18.7% and is now trading at $1.83. View the best growth stocks for 2024 here. How were TherapeuticsMD's earnings last quarter? TherapeuticsMD, Inc. (NASDAQ:TXMD) posted its earnings results on Friday, May, 10th. The company reported ($0.07) earnings per share for the quarter. The business earned $0.31 million during the quarter. When did TherapeuticsMD's stock split? TherapeuticsMD's stock reverse split before market open on Monday, May 9th 2022. The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split. How do I buy shares of TherapeuticsMD? Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. What other stocks do shareholders of TherapeuticsMD own? Based on aggregate information from My MarketBeat watchlists, some other companies that TherapeuticsMD investors own include OPKO Health (OPK), Verastem (VSTM), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Sorrento Therapeutics (SRNE) and Gilead Sciences (GILD). This page (NASDAQ:TXMD) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredGet out of cash before the Fed's next meeting"How I 6X-ed my wife's 401K in 1 year" At the peak of the dot-com boom, a former hedge fund manager put all...Stansberry Research | SponsoredNext opportunity for crypto millionsThe Bitcoin halving is the #1 creator of "crypto millionaires". That's because historically, every halving has...Crypto 101 Media | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | Sponsored4 Steps to Survive the Coming Market CrashCracks threaten us with a widespread collapse unlike anything we've seen in our lifetime. During this prese...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TherapeuticsMD, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TherapeuticsMD With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
